Publications Database

Geraghty M. E. et al. (2010)

Nutritional interventions and therapies in autism: A spectrum of what we know: Part 2

ICAN: Infant, Child, and Adolescent Nutrition

2(2), pp. 120-133

Read Abstract (New Window)

Gilbert D. (2008)

Regarding 'omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study'.

Biological Psychiatry

63(2), e13; author reply e15

Gogou M. , Kolios G.

The effect of dietary supplements on clinical aspects of autism spectrum disorder: A systematic review of the literature.

Brain and Development

Read Abstract (New Window)

Hendren. R. L. (2013)

Autism: biomedical complementary treatment approaches.

Child and Adolescent Psychiatric Clinics of North America

22(3), pp. 443-456.

Read Abstract (New Window)

Horvath A. , Lukasik J. , Szajewska H. (2017)

ω-3 fatty acid supplementation does not affect autism spectrum disorder in children: A systematic review and meta-analysis.

Journal of Nutrition

March, 147(3), pp. 367-376.

Read Abstract (New Window)

James S. , Montgomery P. , Williams K. J. (2011)

Omega-3 fatty acids supplementation for autism spectrum disorders (ASD)

Cochrane Database of Systematic Reviews

Read Abstract (New Window) Read Full (New Window)

Johnson M. et al. (2009)

Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents.

Journal of Attention Disorders

12(5), pp. 394-401.

Read Abstract (New Window)

Johnson C. R. et al. (2010)

Polyunsaturated fatty acid supplementation in young children with autism.

Journal of Developmental and Physical Disabilities

22(1), pp. 1-10.

Read Abstract (New Window)

Keim S. A. et al. (2018)

ω-3 and ω-6 fatty acid supplementation may reduce autism symptoms based on parent report in preterm toddlers.

Journal of Nutrition

148(2), pp. 227-235.

Read Abstract (New Window)

Lee Y. J. et al. (2014)

Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder.

Clinical Psychopharmacology and Neuroscience

Read Abstract (New Window) Read Full (New Window)

Li Y. J. , Li Y. , Xiang D.

Supplement intervention associated with nutritional deficiencies in autism spectrum disorders: a systematic review.

European Journal of Nutrition

Read Abstract (New Window)

Lofthouse N. et al. (2012)

A review of complementary and alternative treatments for autism spectrum disorders.

Autism Research and Treatment

Read Abstract (New Window)

Lyra L. et al. (2017)

What do Cochrane systematic reviews say about interventions for autism spectrum disorders?

Sao Paulo Medical Journal

March-April, 135(2), pp. 192-201.

Read Abstract (New Window) Read Full (New Window)

Mankad D. et al. (2015)

A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism.

Molecular Autism

Read Abstract (New Window) Read Full (New Window)

Mazahery H. et al. (2017)

Relationship between long chain n-3 polyunsaturated fatty acids and autism spectrum disorder: Systematic review and meta-analysis of case-control and randomised controlled trials.

Nutrients

Read Abstract (New Window)

Meguid N. A. et al. (2008)

Role of polyunsaturated fatty acids in the management of Egyptian children with autism.

Clinical Biochemistry

Read Abstract (New Window)

Meiri G. , Bichovsky Y. , Belmaker R. (2009)

Omega 3 fatty acid treatment in autism.

Journal of Child and Adolescent Psychopharmacology

19(4), pp. 449-451

Read Abstract (New Window)

Office of Dietary Supplements (2005)

Dietary supplement fact sheet: Omega 3 fatty acids and health.

Bethesda, MD: Office of Dietary Supplements

Read Full (New Window)

Ooi Y. P. et al. (2015)

Omega-3 fatty acids in the management of autism spectrum disorders: findings from an open-label pilot study in Singapore.

European Journal of Clinical Nutrition

August, 69(8), pp. 969-671.

Read Abstract (New Window)

Parellada M. et al. (2017)

Randomized trial of omega-3 for autism spectrum disorders: Effect on cell membrane composition and behavior.

European Neuropsychopharmacology

December, 27(12), pp. 1319-1330.

Read Abstract (New Window)